Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00488267 · ClinicalTrials.gov registry record · Phase 3

Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee

A Phase 3 study of Osteoarthritis, sponsored by ZARS Pharma.

Completed
Registry status
Phase 3
Development phase
679
Enrollment target
20
Study locations

NCT00488267 is a Phase 3 study of Osteoarthritis that has completed, run by ZARS Pharma. The registered enrollment target is 679 participants, below the 813-participant average among 135 other Osteoarthritis trials with a reported enrollment target (16% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00488267, a Phase 3 study of Osteoarthritis, has completed, sponsored by ZARS Pharma.

COMPLETED
Registry status
Phase 3
Development phase
679 participants
Enrollment target
20
Study locations

Study Summary

ThermoProfen is a transdermal ketoprofen patch that is integrated with a long-lasting CHADD (Controlled Heat-Assisted Drug Delivery) unit for the treatment of chronic pain associated with osteoarthritis. This study will evaluate ThermoProfen for the treatment of mild to moderate pain associated with osteoarthritis of the knee in adults.

Conditions Studied

Osteoarthritis

Interventions

  • DRUG ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System)
  • DRUG Placebo Matrix/CHADD Patch
  • DRUG Ketoprofen matrix/placebo CHADD Patch

Study Locations (20)

Florida

  • - Clearwater
  • - Jupiter
  • - Pembroke Pines
  • - South Miami
  • - Tampa

California

  • - Anaheim
  • - Buena Park
  • - San Diego
  • - Westlake Village

Connecticut

  • - Hamden
  • - Milford

Maryland

  • - Baltimore
  • - Wheaton

Arizona

  • - Peoria

Idaho

  • - Boise

Illinois

  • - Springfield

Indiana

  • - Evansville

Trial Details

FieldValue
Enrollment Target 679 participants
Start Date 2007-06
Est. Completion 2008-09
Phase Phase 3

Sponsor

ZARS Pharma

23 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00488267

The ClinicalTrials.gov registry entry for NCT00488267 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 679 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 813-participant average among 135 other Osteoarthritis trials with a reported enrollment target (16% lower). The listed sponsor is ZARS Pharma, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 3 interventions - of which ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System) is the first listed.

NCT00488267 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, California, Connecticut.

Frequently Asked Questions

What is clinical trial NCT00488267 about?

NCT00488267 is a clinical study titled "Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee". ThermoProfen is a transdermal ketoprofen patch that is integrated with a long-lasting CHADD (Controlled Heat-Assisted Drug Delivery) unit for the treatment of chronic pain associated with osteoarthritis. This study will evaluate ThermoProfen for the treatment of mild to moderate pain associated with...

What is the current status of trial NCT00488267?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 679 participants. The study started on 2007-06. Estimated completion is 2008-09.

What conditions does trial NCT00488267 study?

This clinical trial studies the following conditions: Osteoarthritis.

What interventions are being tested in trial NCT00488267?

The interventions under investigation include: ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System) (DRUG), Placebo Matrix/CHADD Patch (DRUG), Ketoprofen matrix/placebo CHADD Patch (DRUG).

Who is sponsoring clinical trial NCT00488267?

This trial is sponsored by ZARS Pharma, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00488267 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Osteoarthritis

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.